Cargando…

NPRL2 Sensitizes Human Non-Small Cell Lung Cancer (NSCLC) Cells to Cisplatin Treatment by Regulating Key Components in the DNA Repair Pathway

NPRL2, one of the tumor suppressor genes residing in a 120-kb homozygous deletion region of human chromosome band 3p21.3, has a high degree of amino acid sequence homology with the nitrogen permease regulator 2 (NPR2) yeast gene, and mutations of NPRL2 in yeast cells are associated with resistance t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jayachandran, Gitanjali, Ueda, Kentaro, Wang, Bingbing, Roth, Jack A., Ji, Lin
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2916838/ https://www.ncbi.nlm.nih.gov/pubmed/20700484 http://dx.doi.org/10.1371/journal.pone.0011994

Ejemplares similares

Dorsal telencephalon-specific Nprl2- and Nprl3-knockout mice: novel mouse models for GATORopathy
por: Ishida, Saeko, et al.
Publicado: (2021)

Clinical phenotypic and genotypic characterization of NPRL3-related epilepsy
por: Zhang, Hongwei, et al.
Publicado: (2023)

Bioinformatics analysis of the prognostic and immunotherapeutic significance of NPRL2 in stomach adenocarcinoma
por: Pi, Yilin, et al.
Publicado: (2022)

Tumor suppressor NPRL2 induces ROS production and DNA damage response
por: Ma, Yinxing, et al.
Publicado: (2017)

TUSC2 downregulates PD-L1 expression in non-small cell lung cancer (NSCLC)
por: Cao, Xiaobo, et al.
Publicado: (2017)

MPG and NPRL3 Polymorphisms Are Associated with Ischemic Stroke Susceptibility and Post-Stroke Mortality
por: Ryu, Chang Soo, et al.
Publicado: (2020)

The TORC1 inhibitor Nprl2 protects age-related digestive function in Drosophila
por: Xi, Junmeng, et al.
Publicado: (2019)

Increased glycine contributes to synaptic dysfunction and early mortality in Nprl2 seizure model
por: Dentel, Brianne, et al.
Publicado: (2022)

The clinical features of familial focal epilepsy with variable foci and NPRL3 gene variant
por: Wang, Yue, et al.
Publicado: (2023)

Identification of solamargine as a cisplatin sensitizer through phenotypical screening in cisplatin-resistant NSCLC organoids
por: Han, Yi, et al.
Publicado: (2022)

Base excision repair-mediated resistance to cisplatin in KRAS(G12C) mutant NSCLC cells
por: Caiola, Elisa, et al.
Publicado: (2015)

Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2
por: Wang, Dongliang, et al.
Publicado: (2021)

NPRL-Z-1, as a New Topoisomerase II Poison, Induces Cell Apoptosis and ROS Generation in Human Renal Carcinoma Cells
por: Wu, Szu-Ying, et al.
Publicado: (2014)

Phenotypic and Genotypic Characterization of NPRL2-Related Epilepsy: Two Case Reports and Literature Review
por: Sun, Yulin, et al.
Publicado: (2021)

FKBP39 controls nutrient dependent Nprl3 expression and TORC1 activity in Drosophila
por: Zhou, Ying, et al.
Publicado: (2021)

Neurophysiological assessment of cortical activity in DEPDC5- and NPRL3-related epileptic mTORopathies
por: Mabika, Madora, et al.
Publicado: (2023)

Overexpression of Nitrogen Permease Regulator Like-2 (NPRL2) Enhances Sensitivity to Irinotecan (CPT-11) in Colon Cancer Cells by Activating the DNA Damage Checkpoint Pathway
por: Liu, Shasha, et al.
Publicado: (2018)

Silencing of Twist1 sensitizes NSCLC cells to cisplatin via AMPK-activated mTOR inhibition
por: Jin, H-O, et al.
Publicado: (2012)

Inhibition of SMYD2 Sensitized Cisplatin to Resistant Cells in NSCLC Through Activating p53 Pathway
por: Shang, Lei, et al.
Publicado: (2019)

Opposing functions of β-arrestin 1 and 2 in Parkinson’s disease via microglia inflammation and Nprl3
por: Fang, Yinquan, et al.
Publicado: (2021)

Refining the electroclinical spectrum of NPRL3‐related epilepsy: A novel multiplex family and literature review
por: Dainelli, Alice, et al.
Publicado: (2023)

Overexpression of miR-216b sensitizes NSCLC cells to cisplatin-induced apoptosis by targeting c-Jun
por: Huang, Gang, et al.
Publicado: (2017)

Midazolam increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via the miR-194-5p/HOOK3 axis
por: Sun, Tingting, et al.
Publicado: (2021)

Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer
por: Senchenko, Vera N, et al.
Publicado: (2010)

Inhaled Cisplatin for NSCLC: Facts and Results
por: Kosmidis, Christoforos, et al.
Publicado: (2019)

Pharmacogenomics of Cisplatin Sensitivity in Non-small Cell Lung Cancer
por: Rose, Maimon C., et al.
Publicado: (2014)

Chemotherapy with cisplatin and vinorelbine for elderly patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC)
por: Pereira, José Rodrigues, et al.
Publicado: (2004)

NPRL2 Inhibition of mTORC1 Controls Sodium Channel Expression and Brain Amino Acid Homeostasis
por: Hui, Jeremy B., et al.
Publicado: (2022)

Laser interstitial thermal therapy for NPRL3-related epilepsy with multiple seizure foci: A case report
por: Abumurad, Sumayyah, et al.
Publicado: (2021)

NPRL2 down‐regulation facilitates the growth of hepatocellular carcinoma via the mTOR pathway and autophagy suppression
por: Wang, Ya‐Chin, et al.
Publicado: (2022)

RBM5 reduces small cell lung cancer growth, increases cisplatin sensitivity and regulates key transformation-associated pathways
por: Loiselle, Julie J., et al.
Publicado: (2016)

Pembrolizumab—the “KEY” to an evolving landscape in treatment of squamous non-small cell lung cancer (NSCLC)
por: Yellala, Amulya, et al.
Publicado: (2020)

A small molecule inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC
por: Dean, E J, et al.
Publicado: (2010)

Trichosanthin enhances sensitivity of non-small cell lung cancer (NSCLC) TRAIL-resistance cells
por: You, Chengcheng, et al.
Publicado: (2018)

Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)—validation in two independent cohorts
por: Buhl, Ida Kappel, et al.
Publicado: (2018)

Metabolomics unveils the mechanism of Bufei Huayu decoction in combination with cisplatin against non-small cell lung cancer (NSCLC)
por: Feng, Yuan, et al.
Publicado: (2023)

Metformin enhances the radiosensitizing effect of cisplatin in non-small cell lung cancer cell lines with different cisplatin sensitivities
por: Riaz, Muhammad Assad, et al.
Publicado: (2019)

A splicing variation in NPRL2 causing familial focal epilepsy with variable foci: additional cases and literature review
por: Zhang, Jia, et al.
Publicado: (2021)

A Novel Loss-of-Function Mutation in the NPRL3 Gene Identified in Chinese Familial Focal Epilepsy with Variable Foci
por: Li, Youzhi, et al.
Publicado: (2021)

YBX1 mediates autophagy by targeting p110β and decreasing the sensitivity to cisplatin in NSCLC
por: Cui, Yanwei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m9khe01e41li0fp3964qsuh6aa